Nuo Therapeutics Statistics
Total Valuation
AURX has a market cap or net worth of 78.04 million. The enterprise value is 77.86 million.
| Market Cap | 78.04M |
| Enterprise Value | 77.86M |
Important Dates
The last earnings date was Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURX has 47.88 million shares outstanding. The number of shares has increased by 7.39% in one year.
| Current Share Class | 47.88M |
| Shares Outstanding | 47.88M |
| Shares Change (YoY) | +7.39% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 47.79% |
| Owned by Institutions (%) | 2.15% |
| Float | 20.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.01 |
| PB Ratio | -94.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.51 |
| EV / Sales | 39.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -71.02 |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -1,938.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -117.08% |
| Return on Invested Capital (ROIC) | -3,267.86% |
| Return on Capital Employed (ROCE) | -722.21% |
| Revenue Per Employee | 216,712 |
| Profits Per Employee | -274,517 |
| Employee Count | 9 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.33% in the last 52 weeks. The beta is -942.60, so AURX's price volatility has been lower than the market average.
| Beta (5Y) | -942.60 |
| 52-Week Price Change | +117.33% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 1.43 |
| Relative Strength Index (RSI) | 51.30 |
| Average Volume (20 Days) | 12,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, AURX had revenue of 1.95 million and -2.47 million in losses. Loss per share was -0.05.
| Revenue | 1.95M |
| Gross Profit | 1.48M |
| Operating Income | -2.60M |
| Pretax Income | -2.47M |
| Net Income | -2.47M |
| EBITDA | -2.55M |
| EBIT | -2.60M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 316,354 in cash and 131,608 in debt, giving a net cash position of 184,746 or 0.00 per share.
| Cash & Cash Equivalents | 316,354 |
| Total Debt | 131,608 |
| Net Cash | 184,746 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -824,561 |
| Book Value Per Share | -0.02 |
| Working Capital | -145,675 |
Cash Flow
In the last 12 months, operating cash flow was -713,815 and capital expenditures -382,413, giving a free cash flow of -1.10 million.
| Operating Cash Flow | -713,815 |
| Capital Expenditures | -382,413 |
| Free Cash Flow | -1.10M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 76.04%, with operating and profit margins of -133.50% and -126.67%.
| Gross Margin | 76.04% |
| Operating Margin | -133.50% |
| Pretax Margin | -126.67% |
| Profit Margin | -126.67% |
| EBITDA Margin | -130.74% |
| EBIT Margin | -133.50% |
| FCF Margin | n/a |
Dividends & Yields
AURX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.39% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.17% |
| FCF Yield | -1.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AURX has an Altman Z-Score of -25.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.74 |
| Piotroski F-Score | 2 |